Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2025-12-25 @ 11:16 PM
Study NCT ID:
NCT05238493
Status:
COMPLETED
Last Update Posted:
2024-06-27
First Post:
2022-01-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-101
Sponsor:
Veloxis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-25
First Submit QC Date:
None
Study First Post Date:
2022-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-26
Last Update Post Date:
2024-06-27
Last Update Post Date Type:
ACTUAL